InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Karydas Daphne. Officer active across 1 company, notably Mineralys Therapeutics, Inc.. In total, 4 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €65k. Activity tracked since 13 November 2025. The latest transaction was disclosed on 31 March 2026 (Cession). Regulator: SEC (Form 4). All data is free.
4 of 4 declarations
Karydas Daphne is a declarant linked to Mineralys Therapeutics, Inc. (XNAS) as a Director. Across 4 filings in total, the 4 sampled filings cover the period from 2025-11-13 to 2026-04-02, with 0 EUR in buys and 64799 EUR in sells; the modal transaction nature is option exercise.